NSC260594
CAS No. 906718-66-9
NSC260594 ( NSC 260594 )
Catalog No. M16515 CAS No. 906718-66-9
NSC260594 (NSC 260594) is a specific inhibitor of HIV-1 RNA packaging.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC260594
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC260594 (NSC 260594) is a specific inhibitor of HIV-1 RNA packaging.
-
DescriptionNSC260594 (NSC 260594) is a specific inhibitor of HIV-1 RNA packaging, which involves preventing the interaction of Gag with SL3 by stabilizing this small RNA stem-loop which then leads to stabilization of the global packaging signal region (psi or ψ); specifically blocks HIV-1 RNA encapsidation, binds to HIV-1 gRNA and exhibits potent antiviral activity; NSC260594 also is a small molecule inhibitor of the Escherichia coli condensin MukBEF, affects MukB directly.
-
SynonymsNSC 260594
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number906718-66-9
-
Formula Weight504.55
-
Molecular FormulaC29H24N6O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1C=CC(=NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)N=C4C=CN(C5=C4C=C(C=C5)[N+](=O)[O-])C)C=C1
-
Chemical Name4-[(1-methyl-6-nitroquinolin-4-ylidene)amino]-N-[4-[(1-methylpyridin-4-ylidene)amino]phenyl]benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ingemarsdotter CK, et al. Retrovirology. 2018 Mar 14;15(1):25.
2. Zhao H, et al. ACS Infect Dis. 2018 Oct 22. doi: 10.1021/acsinfecdis.8b00222.
2. Zhao H, et al. ACS Infect Dis. 2018 Oct 22. doi: 10.1021/acsinfecdis.8b00222.
molnova catalog
related products
-
HIV-1 integrase inhi...
HIV-1 integrase inhibitor is an HIV-1 integrase inhibitor.
-
HIV-1 Rev (34-50)
HIV-1 Rev (34-50) is a 17 amino acid peptide with anti-HIV-1 activity. HIV-1 Rev (34-50) is derived from the Rev-responsive element-binding domains of Rev in HIV-1.
-
GSK-2838232
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.